A 10-day-old female neonate born in Mumbai presents with poor feeding, irritability, and seizures since day 8 of life. Mother reports the baby was feeding well until day 5. On examination, the infant is hypertonic with exaggerated reflexes and opisthotonus. Blood gas shows metabolic acidosis (pH 7.18, HCO₃⁻ 12 mEq/L). Plasma amino acids show markedly elevated branched-chain amino acids (leucine 8.5 mg/dL, isoleucine 4.2 mg/dL, valine 6.1 mg/dL; normal <3 mg/dL each) and elevated alloisoleucine. Urine has a characteristic maple syrup odour. What is the most likely diagnosis and the most appropriate immediate management?

Explanation

## Diagnosis: Maple Syrup Urine Disease (MSUD) ### Clinical Presentation This neonate exhibits the classic acute neonatal presentation of MSUD: - **Onset:** Days 5–8 of life (after milk feeding establishes protein intake) - **Neurological signs:** Poor feeding, irritability, seizures, hypertonia, opisthotonus (severe arching), exaggerated reflexes - **Metabolic derangement:** Metabolic acidosis (pH 7.18) - **Pathognomonic finding:** Maple syrup odour in urine and sweat ### Biochemistry & Diagnostic Criteria | Feature | MSUD | PKU | Isovaleric Acidemia | Propionic Acidemia | |---------|------|-----|--------------------|-----------| | **Elevated amino acids** | Branched-chain (Leu, Ile, Val) + alloisoleucine | Phenylalanine | Isovaleric acid metabolites | Propionic acid metabolites | | **Alloisoleucine** | **Present (pathognomonic)** | Absent | Absent | Absent | | **Urine odour** | **Maple syrup** | Musty/mousy | Sweaty feet | Rotten cabbage | | **Acidosis** | Yes (metabolic) | No | Yes (severe) | Yes (severe) | | **Onset** | Days 5–8 | Days 5–7 | Days 3–5 | Days 3–5 | | **Neurological severity** | Seizures, hypertonia | Lethargy, hypotonia | Lethargy, poor feeding | Lethargy, poor feeding | **Key Point:** The presence of **elevated branched-chain amino acids + alloisoleucine + maple syrup odour** is diagnostic of MSUD. Alloisoleucine is a pathognomonic marker formed from isoleucine transamination and is virtually absent in other IEMs. ### Pathophysiology MSUD results from deficiency of the **branched-chain α-ketoacid dehydrogenase complex (BCKDC)**, which catalyzes the oxidative decarboxylation of branched-chain amino acids (leucine, isoleucine, valine): ```mermaid flowchart TD A[Branched-chain amino acids: Leu, Ile, Val]:::outcome --> B[BCKDC enzyme complex]:::action B -->|Normal| C[α-ketoacids → TCA cycle]:::outcome B -->|Deficient in MSUD| D[Accumulation of BCAAs and α-ketoacids]:::urgent D --> E[Metabolic acidosis]:::urgent D --> F[Neurotoxicity: cerebral edema, seizures]:::urgent D --> G[Maple syrup odour: from metabolites]:::outcome ``` **High-Yield:** The branched-chain α-ketoacids are highly neurotoxic and cause: - Cerebral edema and increased intracranial pressure - Seizures and hypertonia - Metabolic acidosis - Rapid neurological deterioration if untreated ### Immediate Management **Urgent interventions:** 1. **Protein restriction:** Stop breast milk or standard formula immediately; switch to BCAA-free formula or parenteral nutrition with amino acid solution devoid of leucine, isoleucine, and valine 2. **Thiamine supplementation:** 100–200 mg/day IV or PO — thiamine is a cofactor for BCKDC and may activate residual enzyme activity in some variants (thiamine-responsive MSUD) 3. **Supportive care:** Treat seizures, correct acidosis, monitor for cerebral edema 4. **Monitoring:** Plasma BCAA levels should be monitored; goal is to reduce leucine to <4 mg/dL **Clinical Pearl:** Early diagnosis and aggressive protein restriction within the first 24–48 hours of symptom onset can prevent permanent neurological damage. Delay in treatment leads to irreversible intellectual disability and death. ### MSUD Variants - **Classic (most common):** Severe neonatal presentation, <3% enzyme activity - **Intermediate:** Milder presentation, 3–30% enzyme activity - **Intermittent:** Normal until metabolic stress (infection, surgery) - **Thiamine-responsive:** Responds to high-dose thiamine; rare **Mnemonic:** **MSUD = Maple Syrup Urine Disease = Branched-Chain amino acid problem = Alloisoleucine present** [cite:Park 26e Ch 9; Ghai Pediatrics 10e Ch 12]